Navigation Links
Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/10/2011

arch agreements

--500,000100,000Total revenues

156,352208,6521,480,362892,644Operating expenses:Research and development

6,940,5647,573,25132,797,67234,416,983Marketing

1,995,716194,8335,051,0061,049,760General and administrative

3,710,7392,074,19212,499,8778,024,138Total operating expenses

12,647,0199,842,27650,348,55543,490,881Loss from operations

(12,490,667)(9,633,624)(48,868,193)(42,598,237)Interest income and other, net

227,89955,025329,290363,998Consolidated net loss

$(12,262,768)$ (9,578,599)$(48,538,903)$(42,234,239)Net loss attributable to noncontrolling interest

316,766141,6821,199,161141,682 Net loss attributable to Optimer Pharmaceuticals, Inc. common stockholders

$(11,946,002)$ (9,436,917)$(47,339,742)$(42,092,557)Basic and diluted net loss per share attributable to common stockholders

$
(0.31)$
(0.28)$
(1.25)$
(1.30)Shares used to compute basic and diluted net  loss per share attributable to common stockholders

39,140,21433,117,09537,830,45232,468,702Optimer Pharmaceuticals, Inc.Consolidated Balance SheetsYear Ended December 31,20102009ASSETSCurrent assets:Cash and cash equivalents

$  19,861,924$ 17,054,328Short-term investments

29,553,50621,131,145Prepaid expenses and other current assets

516,859416,859Total current assets

49,932,28938,602,332Property and equipment, net

697,683672,896Long-term investments

882,000882,000Other assets

508,190498,762Total assets

$  52,020,162$ 40,655,990LIABILITIES  AND STOCKHOLDERS'  EQUITYCurrent liabilities:Accounts payable

$
2,307,820$   2,625,240Accrued expenses

2,385,0465,025,669Total current liabilities

$
4,692,866$   7,650,909Deferred rent

141,138253,474Commitments and contingencies

--Stockholders’ equity

47,186,15832,751,607Total liabilities and stockholders’ e
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on ... is a professional and in-depth market survey ... The report firstly reviews the basic information ... and manufacturing technology. The report then explores ... Hydrochloride listing their product specification, capacity, Production ...
(Date:9/19/2014)... , Sept. 19, 2014 Kiromic, LLC, a ... of Kent Hance , the former chancellor of Texas ... retired as chancellor in July 2014, after raising $1.2 billion ... that Kent Hance , the most successful chancellor in ... team not only as an investor, but also as our ...
(Date:9/19/2014)... CHICAGO , Sept. 19, 2014  4WEB Medical ... of 3D-printed foot and ankle osteotomy implants on ... and Ankle Society annual meeting in Chicago ... for all of a surgeon,s osteotomy needs with 74 size ... wedge systems had smaller offerings of only 15 to 18 ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 24WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
... budget pressures, countries around the world are making ... lure the biopharmaceutical research sector away from the ... Technology Partnership Practice. The study, commissioned ... (PhRMA), further found that while many countries are ...
...   Accuray Incorporated (Nasdaq: ARAY ), ... of Richard Pettingill, LFACHE as a member of the ... Richard Pettingill,s career as a healthcare executive ... variety of prominent organizations. Most recently, Pettingill, who is ...
Cached Medicine Technology:New Study Details Foreign Efforts To Lure Biopharmaceutical Companies 2New Study Details Foreign Efforts To Lure Biopharmaceutical Companies 3Accuray Appoints Richard Pettingill, LFACHE to Board of Directors 2Accuray Appoints Richard Pettingill, LFACHE to Board of Directors 3
(Date:9/20/2014)... September 20, 2014 iFitDress.com, the popular ... for women, has recently unveiled its new collection of ... sale for special offer on these new outfits; it ... season. All customers can now buy cheap cocktail ... company’s sales representative says, “We have extensive experience in ...
(Date:9/20/2014)... 20, 2014 "As a nurse, patients always ... said an inventor from Tamaqua, Pa. "The reason that they ... backs of their chairs. My invention enables them to check ... Oxygen Sensor to make it easier to monitor the contents ... knows when the tank is low. It allows changeovers to ...
(Date:9/20/2014)... Wisconsin (PRWEB) September 20, 2014 QueenBeeTickets.com ... the young star’s tour performances. She will visit many ... of February until the 16th of April. , ... Grande Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s ... opportunity to see their favorite young singer in a ...
(Date:9/20/2014)... 20, 2014 The first federal bellwether ... in its third week in the U.S. District Court, ... Court documents indicate that the week opened in ... from a DePuy Orthopaedics vice president, who discussed the ... company’s Pinnacle hip replacement. According to Reuters, the executive ...
(Date:9/19/2014)... Columbus, OH (PRWEB) September 20, 2014 ... Philadelphia Court of Common Pleas where a meeting took ... Risperdal side-effects complaints pending in the court’s mass ... scheduled to meet this past week at the Complex ... complaints are consolidated for pretrial proceedings. The Risperdal lawsuits ...
Breaking Medicine News(10 mins):Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 2Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 3Health News:Risperdal Lawsuits Move Forward As Attorneys Meet To Discuss Litigation, Reports Wright & Schulte LLC 4
... combining a technology called optical tomography with standard ... from non-cancerous lesions--and potentially reduce the number of ... 15 percent of women who undergo a breast ... women to experience unnecessary anxiety, discomfort and expense. ...
... Mayo clinic, is working on improving the host immune ... therapy with tumor components so that it produces immune ... has shown effective treatment against HIV treatment, by stimulating ... of immune cells in the body which is made ...
... One of the main challenges faced by dentists since times ... the satisfaction of their patients. The problem of missing teeth ... or simply old age. Traditionally, complete dentures have performed the ... be said that they were a compromise as far as ...
... Jefferson Medical College had found a way to check ... associated with inserting a medical device can be devastating, ... money. ,Now, researchers have found a way ... titanium, a material used in orthopedic implants. The proof-of-principle ...
... Organisation one in three women and one in seven ... point after the age of 50.The recommended daily// intake of ... 1000mg. Calcium, together with vitamin D is crucial for maintaining ... osteoporosis in later life. Between the ages of 9 to ...
... has been known to be associated with health hazards ... it is known not until recently that rheumatoid arthritis ... mineraloil., ,The exact causative factor rheumatiod factor remains ... environmental fcators have been help responsible to a certain ...
Cached Medicine News:
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: